Symbol
| ACSL4
| contributors: mct - updated : 06-10-2017
|
HGNC name
| acyl-CoA synthetase long-chain family member 4
|
HGNC id
| 3571
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in breast cancer, colon and hepatocellular carcinoma | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | digestive | liver | |
new potential therapeutic target for Hepatocellular Carcinoma as an independent adverse prognostic parameter | cancer | | | |
ACSL4 inhibition is a viable therapeutic approach to preventing ferroptosis-related diseases |
| | | |
| mice heterozygocis for Facl4 deficiency (Cho, 2001) |